FDA 483 - Zoetis Belgium S.A. - November 22, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Zoetis Belgium S.A., a sterile drug products manufacturer in Louvain-la-Neuve, Belgium, was cited for significant deficiencies in its quality control and manufacturing processes. The inspection revealed failures in preventing microbiological contamination, adhering to stability testing programs, thoroughly investigating customer complaints, and establishing adequate production controls for visual particulate inspection. These issues indicate a lack of robust quality assurance for sterile drug products.
ID · 03eafc64-063e-413b-bb2b-3741149a2127